Literature DB >> 29407132

Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.

Satoru Mitomo1, Richard J Jabbour2, Yusuke Watanabe3, Antonio Mangieri1, Marco Ancona1, Damiano Regazzoli1, Akihito Tanaka1, Akihiro Nakajima3, Toru Naganuma3, Francesco Giannini1, Azeem Latib1, Sunao Nakamura3, Antonio Colombo4.   

Abstract

BACKGROUND: There are only a limited number of studies comparing clinical outcomes after treatment of right coronary artery (RCA) aorto-ostial (AO) lesions with early (E-) and new (N-) generation drug-eluting stents (DES).
METHODS: From January 2005 to December 2013, 334 de novo RCA AO lesions treated with DES (E-:142 lesions, N-:192 lesions) at 2 high-volume centers (Italy and Japan) were included in this study. The primary endpoint was target lesion failure (TLF) defined as composite of cardiac mortality, target vessel myocardial infarction, and target lesion revascularization (TLR).
RESULTS: Baseline and lesion characteristics were well balanced between the 2 groups. The size of the stents deployed (3.35±0.37mm vs 3.39±0.33mm, p=0.29) and non-compliant balloons used for post-dilatation (3.55±0.38mm vs 3.62±0.47mm, p=0.21) were similar between the two groups. The median follow-up period was 1432 (IQR: 703-2197) days in total population. The cumulative rate of TLF at 3years was significantly higher in E-DES group when compared with N-DES group (37.7% vs 14.2%, p<0.001), which was mainly driven by TLR (38.0% vs 11.0%, p<0.001). Multivariable analysis revealed that N-DES [HR 0.22 (0.13-0.38), p<0.001], stent underexpansion [HR 10.59 (6.23-17.97), p<0.001], excessive aortic stent protrusion [HR 3.12 (1.87-5.23), p<0.001], and proximal stent overlap [HR 1.74 (1.03-2.95), p=0.03] were independent predictors of TLF.
CONCLUSION: For the treatment of RCA AO lesions, N-DES were associated with a lower incidence of TLF at 3years when compared with E-DES. N-DES use and suboptimal implantation characteristics were independent predictors of TLF.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug-eluting stent; Percutaneous coronary intervention; Right coronary artery aosto-ostial lesion

Mesh:

Year:  2018        PMID: 29407132     DOI: 10.1016/j.ijcard.2017.10.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions.

Authors:  Matteo De Rosa; Gaetano Santulli
Journal:  Int J Cardiol       Date:  2018-01-28       Impact factor: 4.164

2.  Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention.

Authors:  Koichi Ohashi; Daisuke Abe; Norihiro Kuroki; Takao Yuba; Kou Suzuki
Journal:  Heart Vessels       Date:  2019-04-26       Impact factor: 2.037

3.  Late onset of coronary ostial stenosis following surgical aortic valve replacement in a patient with anomalous origin of the right coronary artery.

Authors:  Motoyoshi Takahara; Yuta Imai; Fumihiro Miyashita; Yuki Uchio; Masahiro Makino; Motoki Uchihashi; Satoshi Kaimoto; Mitsuyoshi Hadase; Hiroyuki Kurata; Takashi Nakamura
Journal:  J Cardiol Cases       Date:  2021-07-30

4.  Clinical Outcomes after Additional Dynamic Renal® Stent Implantation for Stent Recoil in Ostial Coronary Lesions.

Authors:  Bachir Abdulrahman; Kambis Mashayekhi; Péter Tajti; Miroslaw Ferenc; Christian Marc Valina; Willibald Hochholzer; Franz-Josef Neumann; Thomas Georg Nührenberg
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.